Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection

Intravenous infusion, once every 2 weeks (Q2W). It is recommended that the infusion time of the first cycle should be ≥ 3 hours. If no infusion reaction occurs, the subsequent circulation can be completed within 1-2 hours.